IM Cannabis (IMCC) Other financing activities (2020 - 2026)

IM Cannabis' Other financing activities history runs 7 years deep, the most recent figure standing at $316475.3 for Q1 2026.

• On a quarterly basis, Other financing activities rose 15911.56% year-over-year to $316475.3 in Q1 2026; TTM through Mar 2026 was -$461066.2, a 502.5% decrease from a year earlier, with the FY2024 full-year figure at -$46745.6, down 102.58% from the prior year.
• Other financing activities rose to $316475.3 in Q1 2026 per IMCC's latest filing, from -$794212.1 in the prior quarter.
• Across five years, Other financing activities topped out at $10.0 million in Q4 2022 and bottomed at -$3.0 million in Q4 2023.
• The 5-year median for Other financing activities is $10120.4 (2022), against an average of $829691.7.
• Across the five-year window, Other financing activities sank 21076.09% in 2023 and soared 15911.56% in 2026, its largest moves.
• Year by year, Other financing activities stood at $10.0 million in 2022, then slumped by 130.39% to -$3.0 million in 2023, then jumped by 52.36% to -$1.4 million in 2024, then surged by 45.13% to -$794212.1 in 2025, then soared by 139.85% to $316475.3 in 2026.
• Per Business Quant, the three latest IMCC Other financing activities figures stand at $316475.3 (Q1 2026), -$794212.1 (Q3 2025), and $18672.1 (Q2 2025).